Dr. Rafayel Vahratyan, DO

Dr. Vahratyan practices at Henry Mayo Newhall Hospital in Valencia, California, part of Henry Mayo Newhall Hospital.

Dr. Vahratyan's NPI, 1245593458, was assigned on June 21, 2012. Dr. Vahratyan graduated from WesternU College of Osteopathic Medicine of the Pacific in 2012. Dr. Vahratyan holds California license 20A12975.

Dr. Vahratyan's primary practice is Henry Mayo Newhall Hospital, at 23845 McBean Pkwy, Valencia, CA 91355 in Los Angeles County. The practice phone is (661) 253-8000.

Dr. Vahratyan's primary practice is Henry Mayo Newhall Hospital in Valencia, California, part of Henry Mayo Newhall Hospital. Dr. Vahratyan is also affiliated with Arrowhead Regional Medical Center. The medical group on file is SCCT Medical Group. Dmand AI also links Dr. Vahratyan to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vahratyan practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Vahratyan's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Vahratyan is board certified in critical care medicine (caq) by the AOA Board of Internal Medicine. Dr. Vahratyan is licensed in California.

Dmand AI lists aneurysm, chronic diabetes, chronic hypertension, depression, heart failure, heart valve disorders, high cholesterol and peripheral vascular disease among the conditions Dr. Vahratyan treats.

CMS data shows 247 Medicare services from Dr. Vahratyan across 3 procedure codes in 2024, for 124 Medicare patients. Medicare paid $40,058 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 124 Medicare patients who saw Dr. Vahratyan in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vahratyan's median patient age at 67, with 44% women.

In 2017, Dr. Vahratyan wrote 11 Medicare Part D claims. They cover 1 drug, with $820 in total drug cost. In 2016, CMS named 27 claims across 2 drugs.

Dr. Vahratyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 43 general payments to Dr. Vahratyan from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $599.

Dr. Vahratyan graduated from WesternU College of Osteopathic Medicine of the Pacific in 2012. Dr. Vahratyan is a member of AOA.

Dr. Vahratyan is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.